bronchiolitis
Conditions
Interventions
Montelukast-treated Group:Add-on treatment with Montelukast
Placebo-treated Group:Add-on treatment with Montelukast
Sponsors
Department of Pediatrics, The First Affiliated Hospital with Nanjing Medical University
Eligibility
Sex/Gender
All
Age
1 Years to 2 Years
Inclusion criteria
Inclusion criteria: (1) Infants aged 2 months to 2 years, and diagnosed as bronchiolitis accordong to the Zhu Futang Textbook of Pediatrics edition 7th; (2) The parents or guardians of the enrolled children had signed the informed consent for their child participating in this study.
Exclusion criteria
Exclusion criteria: Patients who had underlying cardiopulmonary, laryngeal, tracheobronchial disease or other infectious disease or immunodeficiency were not eligible.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical Asthma Score;Relapse Number; | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effect of Montelukas; | — |
Countries
China
Contacts
Public ContactWu Sheng-Hua
Department of Pediatrics, The First Affiliated Hospital with Nanjing Medical University
Outcome results
None listed